Table 1. Reasons for not switching when first met immunological/clinical criteria for switch in patients receiving and not receiving CD4 monitoring.
CD4 monitoring (LCM) | No CD4 monitoring (CDM) | |
Total met clinical (WHO 4 event) or immunological (confirmed CD4<100 cells/mm3) criteria for switch and either switched >8 weeks later or did not switch | 132 (100%) | |
Total met clinical criteria (WHO 4 event) for switch and either switched >8 weeks later or did not switch | 100 (100%) | |
Reason for not initially switching patient reported (details below)* | 42 (32%) | 44 (44%) |
No reason reported but switched within 6 months | 56 (42%) | 33 (33%) |
Reason not reported, not switched within 6 months | 34 (26%) | 23 (23%) |
Switched after 6 months | 27 | 21 |
Died or last seen alive and not switched | 7 | 2 |
Reason for not switching when first met criteria (% of those reporting a reason) | 42 (100%) | 44 (100%) |
Patient judged to be doing well | 30 (71%) | 20 (45%) |
CD4>200 | 19 | N/A |
CD4 100-200 or <100 but still increasing | 9 | N/A |
only been on ART for ∼1 year | 0 | 3 |
clinical judgement that event not related to ART failure ** | 2 | 12 |
client felt well and did not want to switch | 0 | 5 |
On TB treatment with rifampicin | 10 (24%) | 14 (32%) |
Poor adherer/defaulter | 1 (2%) | 4 (9%) |
Too ill to switch | 0 (0%) | 4 (9%) |
Oversight: should have switched | 1 (2%) | 2 (5%) |
based on a retrospective request for reasons why patients had not switched within 8 weeks of first meeting protocol switch criteria.
eg only presumptive diagnosis, responded to treatment for the clinical event, event judged related to recent period off ART, patient being monitored and doing well.